ARRIVE Trial: A Critical Analysis & International Perspective
In 2018, “The ARRIVE Trial: A randomized trial of induction versus expectant management,” was published in the United States. The study involved more than 6,000 healthy, term, nulliparous women, half of which experienced induction of labor (IOL) and half of which experienced expectant management (EM). The goal was to assess the relationship between induction of labor and cesarean birth rate – and the study authors believed they identified a relationship.
When 18.6% of the women in the IOL group experienced cesarean delivery and 22.2% in the EM did, the authors believed they had shown that IOL at 39 weeks in nulliparous women decreases cesarean birth. The study was widely publicized and the suggestion made that the findings should change clinical practice. But is this true?
In this course, instructor Andrea Inchaurrondo, IBCLC, midwife, and nurse, delves deeply into the ARRIVE Trial’s background, methodology, results, and most importantly, implications. You will leave this course with a full understanding of this key research in the maternal and newborn care field.
However, the benefits do not end there. In Inchaurrondo’s course, the ARRIVE Trial becomes a tool for learning how to critically analyze any research study to evaluate for yourself whether it warrants a change in your practice as you care for parents and babies. You will learn or review study design, internal and external validity, selection bias, confounding, and more, so that you can apply these concepts to every study you read, as well as solidify your knowledge for the IBLCE Exam.
This Course Awards:
- 1 Nursing Contact Hour
- 1 R-CERP